Bruce M. Camitta , MD

Hematology and Oncology                       

Title(s): Program director, Cancer Program, and Rebecca Jean Slye Chair in Oncology, Children's Hospital of Wisconsin; professor, Pediatrics, Medical College of Wisconsin.

Education: Medical degree, Johns Hopkins, Baltimore, Md., 1966; residency: Children's Hospital of Pittsburgh, 1966-1968 and Johns Hopkins, 1968-1969; fellowship, Harvard University, Boston Children's Hospital, 1971-74.

Certification(s): Pediatrics, Pediatric Hematology-Oncology.  

Research interests: Aplastic anemia, acute leukemias of childhood and bone marrow transplantation.

Representative publications:

• Camitta BM, Storb R, Thomas ED. Aplastic Anemia: Pathogenesis, Diagnosis, Treatment and Prognosis. New England Journal of Medicine 306:645/712, 1982. 
• Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gaynon P, Gelber R, Heerema N, Korn E, Link M, Murphy S, Pui C-H, Pullen J, Reaman G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Ucken F, Ungerleider R. A Uniform Approach to Risk-Classification and Treatment Assignment for Children with Acute Lymphoblastic Leukemia. Journal of Clinical Oncology 14:18, 1996.
• Mahoney DH, Shuster J, Nitschke R, Lauer S, Winick N, Camitta B. Intermediate Dose Methotrexate with Intravenous Mercaptopurine is Superior to Repetitive Low Dose Oral Methotrexate with Intravenous Mercaptopurine for Children with Lower Risk B-Lineage Acute Lymphoblastic Leukemias: A Pediatric Oncology Group Phase III Trial. Journal of Clinical Oncology 16:246, 1998.
• Arico M, Valsecehi MG, Camitta BM, Schrappe M, Chessells J, Baruchel A, Gaynon P, Sallan S, Janka-Schaub G, Kamps W, Pui C-H, Masera G. Heterogeneity of Treatment Outcome in Children with Philadelphia Chromosome: Positive Acute Lymphoblastic Leukemia. New England Journal of Medicine 342:998, 2000.
• Lauer SJ, Shuster JJ, Mahoney DH, Winick N, Toledano S, Munoz L, Kiefer G, Pullen J, Steuber CP, Camitta BM. A Comparison of Early Intensive Methotrexate/Mercaptopurine with Early Intensive Alternating Combination Chemotherapy for High-Risk B-Precursor Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Phase III Randomized Trial. Leukemia 15:1038, 2001.
•  Pui C-H, Gaynon PS, Boyette JM, Chessels JM, Baruchel A, Kamps W, Silverman LB, Biondi A, Harms DO, Vilmer E, Schrappe M, Camitta B. Outcome of Treatment in Childhood Acute Lymphoblastic Leukaemia with Rearrangements of the 11q23 Chromosomal Region. Lancet 359:1909, 2002.

Current grants:

• Midwest Athletes Against Childhood Cancer (MACC Fund): general support.

Contact information: 8701 Watertown Plank Road, Milwaukee, WI 53226. Phone: (414) 456-4106. Fax: (414) 456-6543. E-mail: bcamitta@mcw.edu.